William Howard Evans

Gap junctions: structure and function (Review)

Gap junctions are plasma membrane spatial microdomains constructed of assemblies of channel proteins called connexins in vertebrates and innexins in invertebrates. The channels provide direct intercellular communication pathways allowing rapid exchange of ions and metabolites up to ~1 kD in size. Approximately 20 connexins are identified in the human or mouse genome, and orthologues are increasingly characterized in other vertebrates. Most cell types express multiple connexin isoforms, making likely the construction of a spectrum of heteromeric hemichannels and heterotypic gap junctions that could provide a structural basis for the charge and size selectivity of these intercellular channels. The precise nature of the potential signalling information traversing junctions in physiologically defined situations remains elusive, but extensive progress has been made in elucidating how connexins are assembled into gap junctions. Also, participation of gap junction hemichannels in the propagation of calcium waves via an extracellular purinergic pathway is emerging. Connexin mutations have been identified in a number of genetically inherited channel communication-opathies. These are detected in connexin 32 in Charcot Marie Tooth-X linked disease, in connexins 26 and 30 in deafness and skin diseases, and in connexins 46 and 50 in hereditary cataracts. Biochemical approaches indicate that many of the mutated connexins are mistargeted to gap junctions and/or fail to oligomerize correctly into hemichannels. Genetic ablation approaches are helping to map out a connexin code and point to specific connexins being required for cell growth and differentiation as well as underwriting basic intercellular communication.

Central role of heterocellular gap junctional communication in endothelium‐dependent relaxations of rabbit arteries

1 The contribution of gap junctions to endothelium‐dependent relaxation was investigated in isolated rabbit conduit artery preparations pre‐constricted by 10 μM phenylephrine (PhE). 2 Acetylcholine (ACh) relaxed the thoracic aorta by ≈60 % and the superior mesenteric artery (SMA) by ≈90 %. A peptide possessing sequence homology with extracellular loop 2 of connexin 43 (Gap 27, 300 μM) inhibited relaxation by ≈40 % in both artery types. Gap 27 also attenuated the endothelium‐dependent component of the relaxation induced by ATP in thoracic aorta but did not modify force development in response to PhE. 3 N G‐nitro‐L‐arginine methyl ester (L‐NAME, 300 μM), an inhibitor of NO synthase, attenuated ACh‐induced relaxation by ≈90 % in the aorta but only by ≈40 % in SMA (P < 0.05). Residual L‐NAME‐insensitive relaxations were almost abolished by 300 μM Gap 27 in aorta and inhibited in a concentration‐dependent fashion in SMA (≈50 % at 100 μM and ≈80 % at 10 mM). Gap 27 similarly attenuated the endothelium‐dependent component of L‐NAME‐insensitive relaxations to ATP in aorta. 4 Responses to cyclopiazonic acid, which stimulates endothelium‐dependent relaxation through a receptor‐independent mechanism, were also attenuated by Gap 27, whereas this peptide exerted no effect on the NO‐mediated relaxation induced by sodium nitroprusside in preparations denuded of endothelium. 5 ACh‐induced relaxation of ‘sandwich’ mounts of aorta or SMA were unaffected by Gap 27 but completely abolished by L‐NAME. 6 We conclude that direct heterocellular communication between the endothelium and smooth muscle contributes to endothelium‐dependent relaxations evoked by both receptor‐dependent and ‐independent mechanisms. The inhibitory effects of Gap 27 peptide do not involve homocellular communication within the vessel wall or modulation of NO release or action.

Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries.

1 Phenylephrine (10 μM) evoked rises in tension in isolated rings of endothelium‐denuded rabbit superior mesenteric artery. These increases consisted of a tonic component with superimposed rhythmic activity, the frequency of which generally remained constant over time but whose amplitude exhibited cycle‐to‐cycle variability. 2 The amplitude, but not the frequency, of the rhythmic activity was affected by a series of short peptides possessing sequence homology with extracellular loops 1 and 2 of connexin 43 (Cx43). Oscillatory behaviour was abolished at concentrations of 100–300 μM (IC50 of 20–30 μM), without change in average tone. No synergy was evident between peptides corresuponding to the extracellular loops, and cytoplasmic loop peptides were biologically inactive. 3 The putative gap junction inhibitor heptanol mimicked the action of the extracellular loop peptides and abolished rhythmic activity at concentrations of 100–300 μM without effects on frequency. However, in marked contrast to the peptides, heptanol completely inhibited the contraction evoked by phenylephrine (IC50, 283 ± 28 μM). 4 The presence of mRNA encoding Cx32, Cx40 and Cx43 was detected in the rabbit superior mesenteric artery by reverse transcriptase‐polymerase chain reaction. Western blot analysis showed that Cx43 was the major connexin in the endothelium‐denuded vessel wall. 5 We conclude that intercellular communication between vascular smooth muscle cells via gap junctions is essential for synchronized rhythmic activity in isolated arterial tissue, whereas tonic force development appears to be independent of cell‐cell coupling. The molecular specificity of the peptide probes employed in the study suggests that the smooth muscle relaxant effects of heptanol may be non‐supecific and unrelated to inhibition of gap junctional communication.

Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication

Intercellular co-operation is a fundamental and widespread feature in tissues and organs. An important mechanism ensuring multicellular homoeostasis involves signalling between cells via gap junctions that directly connect the cytosolic contents of adjacent cells. Cell proliferation and intercellular communication across gap junctions are closely linked, and a number of pathologies in which communication is disrupted are known where connexins, the gap-junctional proteins, are modified. The proteins of gap junctions thus emerge as therapeutic targets inviting the development and exploitation of chemical tools and drugs that specifically influence intercellular communication. Connexin mimetic peptides that correspond to short specific sequences in the two extracellular loops of connexins are a class of benign, specific and reversible inhibitors of gap-junctional communication that have been studied recently in a broad range of cells, tissues and organs. This review summarizes the properties and uses of these short synthetic peptides, and compares their probable mechanism of action with those of a wide range of other less specific traditional gap-junction inhibitors.

The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication

1 We have shown that the endocannabinoid anandamide and its stable analogue methanandamide relax rings of rabbit superior mesenteric artery through endothelium‐dependent and ‐independent mechanisms that are unaffected by blockade of NO synthase and cyclooxygenase. 2 The endothelium‐dependent component of the responses was attenuated by the gap junction inhibitor 18α‐glycyrrhetinic acid (18α‐GA; 50 μm), and a synthetic connexin‐mimetic peptide homologous to the extracellular Gap 27 sequence of connexin 43 (43Gap 27, SRPTEKTIFII; 300 μm). By contrast, the corresponding connexin 40 peptide (40Gap 27, SRPTEKNVFIV) was inactive. 3 The cannabinoid CB1 receptor antagonist SR141716A (10 μm) also attenuated endothelium‐dependent relaxations but this inhibition was not observed with the CB1 receptor antagonist LY320135 (10 μm). Furthermore, SR141716A mimicked the effects of 43Gap 27 peptide in blocking Lucifer Yellow dye transfer between coupled COS‐7 cells (a monkey fibroblast cell line), whereas LY320135 was without effect, thus suggesting that the action of SR141716A was directly attributable to effects on gap junctions. 4 The endothelium‐dependent component of cannabinoid‐induced relaxation was also attenuated by AM404 (10 μm), an inhibitor of the high‐affinity anandamide transporter, which was without effect on dye transfer. 5 Taken together, the findings suggest that cannabinoids derived from arachidonic acid gain access to the endothelial cytosol via a transporter mechanism and subsequently stimulate relaxation by promoting diffusion of an to adjacent smooth muscle cells via gap junctions. 6 Relaxations of endothelium‐denuded preparations to anandamide and methanandamide were unaffected by 43Gap 27 peptide, 18α‐GA, SR141716A, AM404 and indomethacin and their genesis remains to be established.

Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-α glycyrrhetinic acid

The gap junction inhibitor 18‐α‐glycyrrhetinic acid (α‐GA, 100 μM) attenuated endothelium‐dependent relaxations to acetylcholine and cyclopiazonic acid by ∼20% in rings of pre‐constricted rabbit iliac artery. The nitric oxide synthase inhibitor NG‐nitro‐L‐arginine methyl ester (L‐NAME, 300 μM) inhibited relaxations to both agents by ∼65% and these were further attenuated by α‐GA to <10% of control. In endothelium‐denuded preparations, relaxations to sodium nitroprusside were not affected by α‐GA. Heterocellular gap junctional communication may therefore account for nitric oxide‐independent relaxations evoked both by receptor‐dependent and ‐independent mechanisms in rabbit iliac artery.

Gap junctions in the adult cerebral cortex: Regional differences in their distribution and cellular expression of connexins

Gap junctions are membrane channels that mediate electrical and metabolic coupling between adjacent cells. Immunocytochemical analysis by using a panel of anti‐connexin antibodies, as well as electron microscopy of thin sections and freeze‐fracture replicas, has shown that gap junctions and their constituent proteins are abundant in the cerebral cortex of the adult rat. Their frequency and distribution vary in different cortical regions, which may reflect differences in the cellular and functional organization of these areas of the cortex. Gap junctions were identified between glial cells and, less frequently, between neuronal elements. Heterologous junctions were also identified between astrocytes and oligodendrocytes and between neurons and glia; the latter category included abundant junctions between astrocytic processes and neurons. Double‐antibody labelling experiments in tissue sections and in acutely dissociated cells showed that connexin 32 was expressed in neurons and oligodendrocytes, whereas connexin 43, widely believed to be expressed only in astrocytes, was also localized in a population of cortical neurons. These results show that gap junctions can provide a major nonsynaptic means of communication between cortical cell types.

Photoliberating inositol-1, 4, 5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26

Calcium signals can be communicated between cells by the diffusion of a second messenger through gap junction channels or by the release of an extracellular purinergic messenger. We investigated the contribution of these two pathways in endothelial cell lines by photoliberating InsP(3) or calcium from intracellular caged precursors, and recording either the resulting intercellular calcium wave or else the released ATP with a luciferin/luciferase assay. Photoliberating InsP(3) in a single cell within a confluent culture triggered an intercellular calcium wave, which was inhibited by the gap junction blocker alpha-glycyrrhetinic acid (alpha-GA), the connexin mimetic peptide gap 26, the purinergic inhibitors suramin, PPADS and apyrase and by purinergic receptor desensitisation. InsP(3)-triggered calcium waves were able to cross 20 microm wide cell-free zones. Photoliberating InsP(3) triggered ATP release that was blocked by buffering intracellular calcium with BAPTA and by applying gap 26. Gap 26, however, did not inhibit the gap junctional coupling between the cells as measured by fluorescence recovery after photobleaching. Photoliberating calcium did not trigger intercellular calcium waves or ATP release. We conclude that InsP(3)-triggered ATP release through connexin hemichannels contributes to the intercellular propagation of calcium signals.

Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells

Recently, ATP has gained much interest as an extracellular messenger involved in the communication of calcium signals between cells. The mechanism of ATP release is, however, still a matter of debate. In the present study we investigated the possible contribution of connexin hemichannels or ion channels in the release of ATP in GP8, a rat brain endothelial cell line. Release of ATP was triggered by photoactivation of InsP3 or by reducing the extracellular calcium concentration. Both trigger protocols induced ATP release significantly above baseline. InsP3‐triggered ATP release was completely blocked by α‐glycyrrhetinic acid (α‐GA), the connexin mimetic peptides gap 26 and 27, and the trivalent ions gadolinium and lanthanum. ATP release triggered by zero calcium was, in addition to these substances, also blocked by flufenamic acid (FFA), niflumic acid, and NPPB. Gap 27 selectively blocked zero calcium‐triggered ATP release in connexin‐43 transfected HeLa cells, while having no effect in wild‐type and connexin‐32 transfected cells. Of all the agents used, only α‐GA, FFA and NPPB significantly reduced gap junctional coupling. In conclusion, InsP3 and zero calcium‐triggered ATP release show major similarities but also some differences in their sensitivity to the agents applied. It is suggested that both stimuli trigger ATP release through the same mechanism, which is connexin‐dependent, permeable in both directions, potently blocked by connexin mimetic peptides, and consistent with the opening of connexin hemichannels. J. Cell. Physiol. 197: 205–213, 2003© 2003 Wiley‐Liss, Inc.

INTRACELLULAR TRAFFICKING PATHWAYS IN THE ASSEMBLY OF CONNEXINS INTO GAP JUNCTIONS

Trafficking pathways underlying the assembly of connexins into gap junctions were examined using living COS-7 cells expressing a range of connexin-aequorin (Cx-Aeq) chimeras. By measuring the chemiluminescence of the aequorin fusion partner, the translocation of oligomerized connexins from intracellular stores to the plasma membrane was shown to occur at different rates that depended on the connexin isoform. Treatment of COS-7 cells expressing Cx32-Aeq and Cx43-Aeq with brefeldin A inhibited the movement of these chimera to the plasma membrane by 84 ± 4 and 88 ± 4%, respectively. Nocodazole treatment of the cells expressing Cx32-Aeq and Cx43-Aeq produced 29 ± 16 and 4 ± 7% inhibition, respectively. In contrast, the transport of Cx26 to the plasma membrane, studied using a construct (Cx26/43T-Aeq) in which the short cytoplasmic carboxyl-terminal tail of Cx26 was replaced with the extended carboxyl terminus of Cx43, was inhibited 89 ± 5% by nocodazole and was minimally affected by exposure of cells to brefeldin A (17 ±11%). The transfer of Lucifer yellow across gap junctions between cells expressing wild-type Cx32, Cx43, and the corresponding Cx32-Aeq and Cx43-Aeq chimeras was reduced by nocodazole treatment and abolished by brefeldin A treatment. However, the extent of dye coupling between cells expressing wild-type Cx26 or the Cx26/43T-Aeq chimeras was not significantly affected by brefeldin A treatment, but after nocodazole treatment, transfer of dye to neighboring cells was greatly reduced. These contrasting effects of brefeldin A and nocodazole on the trafficking properties and intercellular dye transfer are interpreted to suggest that two pathways contribute to the routing of connexins to the gap junction.